Literature Cited
V. Chobanian, P. Brecher, and C. Chan, Circulat. Res.,56, 755 (1985).
H. R. Davis, I. F. Mullan, and T. Lichtor, Arteriosclerosis,5, 526a (1985).
W. J. Dixon and M. B. Brown, in: Biomedical Computer Programs. Series P, Univ. California Press, Berkeley (1977), p. 185.
J. L. Goldstein, G. K. Ho, S. K. Basu, et al., Proc. Nat. Acad. Sci. USA,78, 333 (1979).
J. R. Kaplan, Eur. Heart J.,8, 928 (1987).
P. Leren, Am. J. Med.,82, 31 (1987).
P. Lindqvist, C. Olsson, C. Nordborg, et al., Atherosclerosis,72, 163 (1988).
A. N. Orekhov, Am. J. Cardiol.,66 (1990) (accepted).
A. N. Orekhov, E. R. Andreeva, A. V. Krushinsky, et al., Am. J. Pathol.,125, 402 (1986).
A. N. Orekhov, E. R. Andreeva, V. V. Tertov, et al., Acta Anat.,119, 99 (1984).
A. N. Orekhov, I. V. Andrianova, M. D. Rekhter, et al., Arteriosclerosis,10, 797a (1990).
A. N. Orekhov, G. N. Baldenkov, V. V. Tertov, et al., J. Cardiovasc. Pharmacol.,12, S66 (1988).
A. N. Orekhov, V. V. Tertov, and I. D. Novikov, Exp. Mol. Pathol.,42, 117 (1985).
A. N. Orekhov, M. Ya. Ruda, G. N. Baldenkov, et al., Am. J. Cardiol.,61, 1116 (1988).
H. Stegemann and K. Stalder, Clin. Chim. Acta,18, 267 (1967).
Rights and permissions
About this article
Cite this article
Andrianova, I.V., Rekhter, M.D., Tertov, V.V. et al. Papaverine abolishes the atherogenic effect of the beta-blocker propranolol. Bull Exp Biol Med 113, 353–356 (1992). https://doi.org/10.1007/BF00783112
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00783112